Clinical Trial Update: Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating malaria as a risk factor for COVID-19 in Western Kenya and Burkina Faso has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Covid-19, Malaria | Phase 3 | Status: COMPLETED